Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
179.04
+0.36 (0.20%)
Aug 13, 2025, 4:00 PM - Market closed
Quest Diagnostics Stock Forecast
Stock Price Forecast
According to 15 professional analysts, the 12-month price target for Quest Diagnostics stock ranges from a low of $172 to a high of $200. The average analyst price target of $185.4 forecasts a 3.55% increase in the stock price over the next year.
Price Target: $185.40 (+3.55%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Quest Diagnostics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 3 | 3 | 3 | 3 | 3 |
Buy | 4 | 4 | 4 | 4 | 4 | 4 |
Hold | 7 | 7 | 7 | 7 | 8 | 8 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 13 | 14 | 14 | 14 | 15 | 15 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
UBS | UBS | Hold Maintains $175 → $180 | Hold | Maintains | $175 → $180 | +0.54% | Jul 23, 2025 |
Truist Securities | Truist Securities | Hold Maintains $190 → $192 | Hold | Maintains | $190 → $192 | +7.24% | Jul 23, 2025 |
Deutsche Bank | Deutsche Bank | Hold Maintains $160 → $178 | Hold | Maintains | $160 → $178 | -0.58% | Jul 23, 2025 |
UBS | UBS | Hold Maintains $176 → $175 | Hold | Maintains | $176 → $175 | -2.26% | Jul 18, 2025 |
JP Morgan | JP Morgan | Hold Maintains $180 → $190 | Hold | Maintains | $180 → $190 | +6.12% | May 6, 2025 |
Financial Forecast
Revenue This Year
10.95B
from 9.87B
Increased by 10.88%
Revenue Next Year
11.35B
from 10.95B
Increased by 3.68%
EPS This Year
9.79
from 7.69
Increased by 27.34%
EPS Next Year
10.61
from 9.79
Increased by 8.39%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 11.5B | 11.9B | 12.5B | ||
Avg | 10.9B | 11.3B | 11.8B | ||
Low | 10.5B | 10.9B | 11.3B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 16.2% | 9.1% | 10.3% | ||
Avg | 10.9% | 3.7% | 3.8% | ||
Low | 6.7% | -0.6% | -0.5% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 10.25 | 11.36 | 12.30 | ||
Avg | 9.79 | 10.61 | 11.46 | ||
Low | 9.43 | 10.00 | 10.70 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 33.3% | 16.0% | 15.9% | ||
Avg | 27.3% | 8.4% | 8.0% | ||
Low | 22.6% | 2.1% | 0.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.